Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.

Adding lenacapavir to HIV treatment effectively simplified complicated regimens while lowering or maintaining virological ...

Data—collected and used the right way—has the power to transform best practices in specialty pharmacy. And the insights from that data is what changes how care is delivered and how clinical trials are ...

Imagine a seamlessly orchestrated flow—studies designed smarter, delivered more smoothly, risks reduced and communications ...

Real-world data is invaluable to healthcare tech developers. This type of data reflects actual patient experiences, treatments and outcomes in diverse, real-world environments — rather than controlled ...

In this free webinar, explore the strategic value of early real-world evidence generation in biotech development, focusing on what data is needed, when it matters and how emerging companies can build ...

The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.

RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO® ...

Verantos today announced it ranked 444 on the Deloitte Technology Fast 500 (TM), a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech ...

Medicaid and commercially insured patients with high adherence to SUBLOCADE® experienced lower relapse rates and reduced healthcare resource utilization Adherence to SUBLOCADE was associated with ...

Panelists discuss how integrating real-world evidence into coverage frameworks can enhance decision-making and align payer policies with actual patient outcomes.

Health Canada is reshaping how medicines move through the regulatory system, pitching its agile licensing framework as a way ...